Teva Pharmaceuticals Inc. surged after sales of branded medications topped expectations, showing that its strategy to expand into that drug category is working. Total revenue last quarter of $4.48 billion beat consensus, driven by a 33% gain for a group of drugs that includes Austedo. Meanwhile, sales of generics — Teva’s core business — missed estimates. The Tel Aviv, Israel-based company has pushed into branded medications that have been drivers of the company’s growth in recent years. The generics business continues to make up the majority of Teva’s revenue. 
Richard Francis, Teva's President and CEO, discusses his company's growth strategy and its move to renew the sale process for its active ingredients business after talks with an unnamed buyer fell through. Richard speaks with Emily Graffeo and Katie Greifeld on Bloomberg Businessweek Daily.

Teva Pharmaceuticals Inc.&nbsp;surged after sales of branded medications topped expectations, showing that its strategy to expand into that drug category is working.&nbsp;Total revenue last quarter of $4.48 billion beat consensus, driven by a 33% gain for a group of drugs that includes Austedo. Meanwhile, sales of generics &mdash; Teva&rsquo;s core business &mdash; missed estimates. The Tel Aviv, Israel-based company has pushed into branded medications that have been drivers of the company&rsquo;s growth in recent years. The generics business continues to make up the majority of Teva&rsquo;s revenue. Richard Francis, Teva's President and CEO, discusses his company's growth strategy and its move to renew the sale process for its active ingredients business after talks with an unnamed buyer fell through. Richard speaks with Emily Graffeo and Katie Greifeld on Bloomberg Businessweek Daily.

Listen for reporting from the magazine that helps global leaders stay ahead. 

Hosts Carol Massar and Tim Stenovec bring you insight on the people, companies and trends shaping today's complex economy.  You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: http://bit.ly/3vTiACF. 

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec bring you insight on the people, companies and trends shaping today's complex economy.&nbsp; You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.&nbsp;

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

Teva Surges After Push Into Branded Drugs Drives Sales Beat

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/eb0d4170-b25f-4166-a366-b38c0171d1b4/transcript

The people, companies and trends shaping the global economy.

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

The US Supreme Court struck down President Donald Trump’s sweeping global tariffs, undercutting his signature economic policy and delivering his biggest legal defeat since he returned to the White House.
Voting 6-3, the court said Trump exceeded his authority by invoking a federal emergency-powers law to impose his “reciprocal” tariffs across the globe as well as targeted import taxes the administration says address fentanyl trafficking.

The justices didn’t address the extent to which importers are entitled to refunds, leaving it to a lower court to sort out those issues. If fully allowed, refunds could total as much as $170 billion — more than half the total revenue Trump’s tariffs have brought in.

Trump said at a press conference that he will reimpose some tariffs using alternative legal tools. The fall-back options tend to be either more cumbersome or more limited than the wide-ranging powers Trump asserted under the International Emergency Economic Powers Act.

Stocks rose on news of the decision given investors previously fretted tariffs would hurt the outlook for economic growth and company earnings. Treasuries extended declines with yields rising broadly and the rate on the benchmark 10-year note climbing to 4.10% as investors priced in the likelihood of lower tax revenues. A Bloomberg gauge of the dollar fell as much as 0.2% before erasing the drop.

Today's show features:
Bloomberg News Supreme Court Reporter Greg Stohr on Supreme Court decision to block Trump’s tariffs
Bloomberg White House Correspondent Kate Sullivan on latest from White House on tariff/Supreme Court news
Olu Sonola, Head of US Economic Research at Fitch Ratings on today's Eco data
Alan Eyre, Distinguished Diplomatic Fellow at Middle East Institute, on how Iran is viewing a potential strike by the U

The people, companies and trends shaping the global economy.
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
The US Supreme Court struck down President Donald Trump&rsquo;s sweeping global tariffs, undercutting his signature economic policy and delivering his biggest legal defeat since he returned to the White House. Voting 6-3, the court said Trump exceeded his authority by invoking a federal emergency-powers law to impose his &ldquo;reciprocal&rdquo; tariffs across the globe as well as targeted import taxes the administration says address fentanyl trafficking.
The justices didn&rsquo;t address the extent to which importers are entitled to refunds, leaving it to a lower court to sort out those issues. If fully allowed, refunds could total as much as $170 billion &mdash; more than half the total revenue Trump&rsquo;s tariffs have brought in.
Trump said at a press conference that he will reimpose some tariffs using alternative legal tools. The fall-back options tend to be either more cumbersome or more limited than the wide-ranging powers Trump asserted under the International Emergency Economic Powers Act.
Stocks rose on news of the decision given investors previously fretted tariffs would hurt the outlook for economic growth and company earnings. Treasuries extended declines with yields rising broadly and the rate on the benchmark 10-year note climbing to 4.10% as investors priced in the likelihood of lower tax revenues. A Bloomberg gauge of the dollar fell as much as 0.2% before erasing the drop.
Today's show features:
<ul>
<li>Bloomberg News Supreme Court Reporter Greg Stohr on Supreme Court decision to block Trump&rsquo;s tariffs</li>
<li>Bloomberg White House Correspondent Kate Sullivan on latest from White House on tariff/Supreme Court news</li>
<li>Olu Sonola, Head of US Economic Research at Fitch Ratings on today's Eco data</li>
<li>Alan Eyre, Distinguished Diplomatic Fellow at Middle East Institute, on how Iran is viewing a potential strike by the U</li>
</ul>

Trump’s Global Tariffs Struck Down by US Supreme Court

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/9fd56c99-0375-4b98-aeb2-b3f7017961cf/transcript

For a few brief, shining moments, the dream of Milton Friedman must have seemed closer to reality in corporate America than ever before. Donald Trump had been reelected president, and the tax cuts and regulatory loosening he’d promised were on the horizon. Whatever leverage ordinary workers had managed to scrape together in the years following the Covid-19 pandemic had mostly been quashed, and surely the incoming administration would take care of what remained. Gone, too, were the days when executives would have to evince corporate disapproval of racism or sexism or homophobia if they didn’t feel like it, as many of them had been goaded into doing during #MeToo or the Black Lives Matter movement. They could get out of talking about politics—which is not quite the same as getting out of politics, period—and get back to maximizing shareholder value however they pleased..

Bloomberg Businessweek Senior Reporter Amanda Mull discusses how corporations have largely avoided criticizing Trump, with some leaders only speaking out after extreme circumstances, such as the killing of a Minnesota man by CBP agents, and even then their statements have been muted and avoided direct condemnation.

For a few brief, shining moments, the dream of Milton Friedman must have seemed closer to reality in corporate America than ever before. Donald Trump had been reelected president, and the tax cuts and regulatory loosening he&rsquo;d promised were on the horizon. Whatever leverage ordinary workers had managed to scrape together in the years following the Covid-19 pandemic had mostly been quashed, and surely the incoming administration would take care of what remained. Gone, too, were the days when executives would have to evince corporate disapproval of racism or sexism or homophobia if they didn&rsquo;t feel like it, as many of them had been goaded into doing during <a href="#MeToo" data-auto-tag="#" data-tag-id="1001" data-destination="#MeToo">#MeToo</a> or the Black Lives Matter movement. They could get out of talking about politics&mdash;which is not quite the same as getting out of politics, period&mdash;and get back to maximizing shareholder value however they pleased..
Bloomberg Businessweek Senior Reporter Amanda Mull discusses how corporations have largely avoided criticizing Trump, with some leaders only speaking out after extreme circumstances, such as the killing of a Minnesota man by CBP agents, and even then their statements have been muted and avoided direct condemnation.

Trump Has Called Bluff on the Era of Good Corporate Citizen

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/3bb4a1c1-ffb0-4a9a-8c77-b3f601749257/transcript

The people, companies and trends shaping the global economy.

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

At least one structured note tied to Blue Owl Capital Inc. is being quoted at just 47 cents on the dollar after the asset manager restricted withdrawals from one of its retail-focused private funds.
The security, which was issued by a subsidiary of Citigroup Inc., is due later this year. Another 2028 note that was offered by a unit of JPMorgan Chase & Co. is quoted at about 68 cents, while a Bank of Nova Scotia instrument partly tied to Blue Owl was at 87 cents, according to data compiled by Bloomberg.

Structured notes are bonds with embedded derivatives, giving holders exposure to a number of assets, from stock prices to currencies and interest rates. There’s generally no secondary market for those bonds, with prices only coming from the banks that arranged them.

Blue Owl’s stock fell as much as 9.4% in New York on Thursday. The notes were already quoted below face value prior to the announcement about the withdrawal restrictions.The depressed prices underscore the pressure on Blue Owl, whose stock has already fallen by about a quarter this year.

The plan to limit withdrawals signaled a reversal from a previous arrangement to resume redemptions this quarter.

Today's show features:
Olivia Fishlow, Bloomberg News Leveraged Finance Reporter, on Blue Owl Drops as Redemption Halt Stirs Private Credit Concern
Dylan Field, Figma CEO, on earnings and collaboration with Anthropic
Kate Gulliver, Chief Financial Officer of Wayfair, on quarterly earnings and the health of the American consumer
Matthew O’Neill and Perri Peltz, co-producers & co-directors of ‘Can’t Look Away: The Case Against Social Media, on Mark Zuckerberg’s Day in Social Media Addiction Trial

The people, companies and trends shaping the global economy.
Watch Carol and Tim LIVE every day on YouTube:&nbsp;<a href="http://bit.ly/3vTiACF" data-destination="rte:bind">http://bit.ly/3vTiACF</a>.
At least one structured note tied to Blue Owl Capital Inc. is being quoted at just 47 cents on the dollar after the asset manager restricted withdrawals from one of its retail-focused private funds. The security, which was issued by a subsidiary of Citigroup Inc., is due later this year. Another 2028 note that was offered by a unit of JPMorgan Chase &amp; Co. is quoted at about 68 cents, while a Bank of Nova Scotia instrument partly tied to Blue Owl was at 87 cents, according to data compiled by Bloomberg.
Structured notes are bonds with embedded derivatives, giving holders exposure to a number of assets, from stock prices to currencies and interest rates. There&rsquo;s generally no secondary market for those bonds, with prices only coming from the banks that arranged them.
Blue Owl&rsquo;s stock fell as much as 9.4% in New York on Thursday. The notes were already quoted below face value prior to the announcement about the withdrawal restrictions.The depressed prices underscore the pressure on Blue Owl, whose stock has already fallen by about a quarter this year.
The plan to limit withdrawals signaled a reversal from a previous arrangement to resume redemptions this quarter.
Today's show features:
<ul>
<li>Olivia Fishlow, Bloomberg News Leveraged Finance Reporter, on Blue Owl Drops as Redemption Halt Stirs Private Credit Concern</li>
<li>Dylan Field, Figma CEO, on earnings and collaboration with Anthropic</li>
<li>Kate Gulliver, Chief Financial Officer of Wayfair, on quarterly earnings and the health of the American consumer</li>
<li>Matthew O&rsquo;Neill and Perri Peltz, co-producers &amp; co-directors of &lsquo;Can&rsquo;t Look Away: The Case Against Social Media, on Mark Zuckerberg&rsquo;s Day in Social Media Addiction Trial</li>
</ul>

A Blue Owl-Linked Structured Note Is Now Worth Just 47 Cents

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/329e3a31-2f53-4cb7-8f83-b3f60173d05e/transcript

Teva Surges After Push Into Branded Drugs Drives Sales Beat

In 1 playlist(s)

Bloomberg Businessweek

Social links

Follow podcast

Recent clips